ICL Israel Net Worth
ICL Israel Net Worth Breakdown | ICL |
ICL Israel Net Worth Analysis
ICL Israel's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ICL Israel's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ICL Israel's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ICL Israel's net worth analysis. One common approach is to calculate ICL Israel's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ICL Israel's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ICL Israel's net worth. This approach calculates the present value of ICL Israel's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ICL Israel's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ICL Israel's net worth. This involves comparing ICL Israel's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ICL Israel's net worth relative to its peers.
Enterprise Value |
|
To determine if ICL Israel is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ICL Israel's net worth research are outlined below:
| About 44.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: ICL Group Ltd Shares Acquired by Cadence Wealth Management LLC |
ICL Israel Quarterly Good Will |
|
ICL Israel uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ICL Israel Chemicals. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ICL Israel's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
ICL Israel Target Price Consensus
ICL target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. ICL Israel's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Hold |
Most ICL analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand ICL stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of ICL Israel Chemicals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationICL Israel Target Price Projection
ICL Israel's current and average target prices are 5.89 and 4.78, respectively. The current price of ICL Israel is the price at which ICL Israel Chemicals is currently trading. On the other hand, ICL Israel's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On ICL Israel Target Price
Know ICL Israel's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ICL Israel is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ICL Israel Chemicals backward and forwards among themselves. ICL Israel's institutional investor refers to the entity that pools money to purchase ICL Israel's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Asset Mgmt Americas Inc | 2024-03-31 | 0.0 | Clal Insurance Enterprises Holdings Ltd | 2024-03-31 | 0.0 | Rfp Financial Group Llc | 2024-03-31 | 0.0 | Northern Trust Corp | 2024-03-31 | 0.0 | Ameriprise Financial Inc | 2024-03-31 | 0.0 | V-square Quantitative Management | 2024-03-31 | 0.0 | Sumitomo Mitsui Trust Holdings Inc | 2024-03-31 | 0.0 | Ifp Advisors, Llc | 2024-03-31 | 0.0 | Arlington Trust Co Llc | 2024-03-31 | 0.0 |
Follow ICL Israel's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 7.73 B.Market Cap |
|
Project ICL Israel's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.04 | 0.04 | |
| Return On Capital Employed | 0.09 | 0.08 | |
| Return On Assets | 0.04 | 0.03 | |
| Return On Equity | 0.07 | 0.07 |
When accessing ICL Israel's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ICL Israel's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ICL Israel's profitability and make more informed investment decisions.
Evaluate ICL Israel's management efficiency
ICL Israel Chemicals has Return on Asset of 0.0429 % which means that on every $100 spent on assets, it made $0.0429 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0772 %, implying that it generated $0.0772 on every 100 dollars invested. ICL Israel's management efficiency ratios could be used to measure how well ICL Israel manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to 0.04. The value of Return On Capital Employed is expected to slide to 0.08. At this time, ICL Israel's Intangible Assets are quite stable compared to the past year. Debt To Assets is expected to rise to 0.22 this year, although the value of Non Current Assets Total will most likely fall to about 5 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.64 | 4.87 | |
| Tangible Book Value Per Share | 3.97 | 4.17 | |
| Enterprise Value Over EBITDA | 6.05 | 10.19 | |
| Price Book Value Ratio | 1.11 | 1.06 | |
| Enterprise Value Multiple | 6.05 | 10.19 | |
| Price Fair Value | 1.11 | 1.06 | |
| Enterprise Value | 8.3 B | 12.4 B |
ICL Israel showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Enterprise Value Revenue 1.4094 | Revenue | Quarterly Revenue Growth (0.05) | Revenue Per Share | Return On Equity |
ICL Israel Corporate Filings
| 13th of March 2025 Other Reports | ViewVerify | |
6K | 12th of March 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 27th of February 2025 Other Reports | ViewVerify | |
| 13th of February 2025 Other Reports | ViewVerify |
ICL Israel Earnings Estimation Breakdown
The calculation of ICL Israel's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of ICL Israel is estimated to be 0.0948 with the future projection ranging from a low of 0.07 to a high of 0.11. Please be aware that this consensus of annual earnings estimates for ICL Israel Chemicals is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.07 Lowest | Expected EPS | 0.11 Highest |
ICL Israel Earnings Projection Consensus
Suppose the current estimates of ICL Israel's value are higher than the current market price of the ICL Israel stock. In this case, investors may conclude that ICL Israel is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and ICL Israel's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 4 | 89.5% | 0.08 | 0.0948 | 0.32 |
ICL Israel Earnings History
Earnings estimate consensus by ICL Israel Chemicals analysts from Wall Street is used by the market to judge ICL Israel's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only ICL Israel's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.ICL Israel Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ICL Israel's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ICL Israel Earnings per Share Projection vs Actual
Actual Earning per Share of ICL Israel refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering ICL Israel Chemicals predict the company's earnings will be in the future. The higher the earnings per share of ICL Israel, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.ICL Israel Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as ICL Israel, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of ICL Israel should always be considered in relation to other companies to make a more educated investment decision.ICL Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact ICL Israel's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-26 | 2024-12-31 | 0.0857 | 0.08 | -0.0057 | 6 | ||
2024-11-11 | 2024-09-30 | 0.08 | 0.11 | 0.03 | 37 | ||
2024-08-14 | 2024-06-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2024-05-09 | 2024-03-31 | 0.09 | 0.09 | 0.0 | 0 | ||
2024-02-28 | 2023-12-31 | 0.08 | 0.1 | 0.02 | 25 | ||
2023-11-08 | 2023-09-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2023-08-09 | 2023-06-30 | 0.13 | 0.13 | 0.0 | 0 | ||
2023-05-10 | 2023-03-31 | 0.21 | 0.23 | 0.02 | 9 | ||
2023-02-15 | 2022-12-31 | 0.29 | 0.28 | -0.01 | 3 | ||
2022-11-09 | 2022-09-30 | 0.45 | 0.49 | 0.04 | 8 | ||
2022-07-27 | 2022-06-30 | 0.53 | 0.58 | 0.05 | 9 | ||
2022-05-11 | 2022-03-31 | 0.33 | 0.51 | 0.18 | 54 | ||
2022-02-09 | 2021-12-31 | 0.16 | 0.26 | 0.1 | 62 | ||
2021-11-04 | 2021-09-30 | 0.14 | 0.17 | 0.03 | 21 | ||
2021-07-28 | 2021-06-30 | 0.09 | 0.11 | 0.02 | 22 | ||
2021-05-06 | 2021-03-31 | 0.06 | 0.11 | 0.05 | 83 | ||
2021-02-11 | 2020-12-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2020-11-12 | 2020-09-30 | 0.03 | 0.05 | 0.02 | 66 | ||
2020-07-29 | 2020-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2020-05-12 | 2020-03-31 | 0.05 | 0.05 | 0.0 | 0 | ||
2020-02-13 | 2019-12-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2019-11-07 | 2019-09-30 | 0.1 | 0.1 | 0.0 | 0 | ||
2019-07-31 | 2019-06-30 | 0.11 | 0.12 | 0.01 | 9 | ||
2019-05-07 | 2019-03-31 | 0.1 | 0.12 | 0.02 | 20 | ||
2019-02-06 | 2018-12-31 | 0.09 | 0.1 | 0.01 | 11 | ||
2018-11-01 | 2018-09-30 | 0.1 | 0.1 | 0.0 | 0 | ||
2018-08-01 | 2018-06-30 | 0.08 | 0.09 | 0.01 | 12 | ||
2018-05-10 | 2018-03-31 | 0.08 | 0.08 | 0.0 | 0 | ||
2018-02-14 | 2017-12-31 | 0.08 | 0.11 | 0.03 | 37 | ||
2017-11-08 | 2017-09-30 | 0.08 | 0.09 | 0.01 | 12 | ||
2017-08-03 | 2017-06-30 | 0.07 | 0.05 | -0.02 | 28 | ||
2017-05-10 | 2017-03-31 | 0.06 | 0.05 | -0.01 | 16 | ||
2017-02-15 | 2016-12-31 | 0.09 | 0.09 | 0.0 | 0 | ||
2016-11-23 | 2016-09-30 | 0.09 | 0.09 | 0.0 | 0 | ||
2016-08-10 | 2016-06-30 | 0.06 | 0.1 | 0.04 | 66 | ||
2016-05-18 | 2016-03-31 | 0.09 | 0.07 | -0.02 | 22 | ||
2016-02-09 | 2015-12-31 | 0.11 | 0.14 | 0.03 | 27 | ||
2015-11-12 | 2015-09-30 | 0.13 | 0.12 | -0.01 | 7 | ||
2015-08-12 | 2015-06-30 | 0.08 | 0.14 | 0.06 | 75 | ||
2015-05-13 | 2015-03-31 | 0.11 | 0.15 | 0.04 | 36 | ||
2015-02-11 | 2014-12-31 | 0.12 | 0.09 | -0.03 | 25 | ||
2014-12-04 | 2014-09-30 | 0.14 | 0.14 | 0.0 | 0 | ||
2014-08-07 | 2014-06-30 | 0.14 | 0.17 | 0.03 | 21 | ||
2009-03-30 | 2008-12-31 | 0.26 | 0.15 | -0.11 | 42 |
ICL Israel Corporate Directors
| Avisar Paz | Director | Profile | |
| Reem Aminoach | Independent Director | Profile | |
| Ruth Ralbag | External Independent Director | Profile | |
| Lior Reitblatt | Independent Director | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.087 | Dividend Share 0.193 | Earnings Share 0.32 | Revenue Per Share | Quarterly Revenue Growth (0.05) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.